Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.

PURPOSE To prospectively determine clinical value of dynamic contrast material-enhanced magnetic resonance (MR) imaging in the evaluation of disease activity in perianal Crohn disease (CD). MATERIALS AND METHODS Patients provided written informed consent. Study approval was waived by an institutional review board. Thirty-three patients with perianal CD underwent pelvic MR imaging; 17 were male (mean age, 37.4 years +/- 10.8 [standard deviation]; age range, 18-54 years) and 16 were female (mean age, 32.0 years +/- 8.3; age range, 16-43 years). Dynamic contrast-enhanced MR imaging was performed; time-intensity curves (TICs) were obtained. Each pixel was classified as one of six predefined TIC shape types. For each MR imaging examination, a region of interest (ROI) was drawn around the fistula on the single section corresponding to the most extensive and most hyperintense lesion; maximum enhancement (ME), slope of enhancement, and TIC shapes were calculated. Absolute and relative numbers of pixels for each curve type were calculated in a two-dimensional ROI. These results were compared with Perianal Disease Activity Index (PDAI), C-reactive protein (CRP) level, an MR imaging-based severity score, and clinical outcome. A Spearman rank correlation test was used to calculate correlation coefficients between dynamic contrast-enhanced MR imaging parameters and reference parameters. A Mann-Whitney U test was used to calculate differences in dynamic contrast-enhanced MR imaging parameters between predefined groups of patients. RESULTS Significant correlations were found between the absolute amounts of the TIC shape types and PDAI and between ROI volume and PDAI. The ratio of quickly enhancing versus slowly enhancing pixels correlated with higher MR imaging scores as did the ROI volume. The absolute amounts of pixels displaying TIC types 2, 3, 4, and 5 correlated significantly with MR imaging score. CRP level showed a significant correlation with mean ME. Larger numbers of quickly enhancing pixels were observed in patients who needed medication changes or developed new abscesses during follow-up. CONCLUSION Dynamic contrast-enhanced MR imaging can help determine disease activity in perianal CD and might be helpful in selecting a subpopulation of patients who should be monitored more closely for development of more extensive disease.

[1]  A. Gasbarrini,et al.  GASTROENTEROLOGY 2006;130:2060–2073 Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis , 2022 .

[2]  Cristina Lavini,et al.  Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. , 2007, Magnetic resonance imaging.

[3]  F. Brahme,et al.  A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn's disease and in ulcerative colitis , 1970, Gut.

[4]  K. Zou,et al.  Correlation and simple linear regression. , 2003, Radiology.

[5]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[6]  H K Genant,et al.  MR imaging of the arthritic rabbit knee joint using albumin-(Gd-DTPA)30 with correlation to histopathology. , 1999, Magnetic resonance imaging.

[7]  R. Brasch,et al.  Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. , 1984, AJR. American journal of roentgenology.

[8]  V. A. Sahni,et al.  Which method is best for imaging of perianal fistula? , 2007, Abdominal Imaging.

[9]  J. Spencer,et al.  Dynamic contrast-enhanced MR imaging of perianal fistulas. , 1996, AJR. American journal of roentgenology.

[10]  S. Halligan,et al.  Imaging of fistula in ano. , 2006, Radiology.

[11]  M Ostergaard,et al.  Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. , 1998, Magnetic resonance imaging.

[12]  P. Siersema,et al.  Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. , 2006, AJR. American journal of roentgenology.

[13]  P. Rutgeerts,et al.  A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. , 2002, Gastroenterology.

[14]  G. Marchal,et al.  Magnetic Resonance Imaging of the Effects of Infliximab on Perianal Fistulizing Crohn's Disease , 2003, American Journal of Gastroenterology.

[15]  H. Tilg,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.

[16]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[17]  K. Tamai,et al.  Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[18]  A. Padhani,et al.  Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.